237 related articles for article (PubMed ID: 29712687)
1. Cross-talk between T Cells and Hematopoietic Stem Cells during Adoptive Cellular Therapy for Malignant Glioma.
Wildes TJ; Grippin A; Dyson KA; Wummer BM; Damiani DJ; Abraham RS; Flores CT; Mitchell DA
Clin Cancer Res; 2018 Aug; 24(16):3955-3966. PubMed ID: 29712687
[No Abstract] [Full Text] [Related]
2. Immunotherapy reverses glioma-driven dysfunction of immune system homeostasis.
DiVita Dean B; Wildes T; Dean J; Yegorov O; Yang C; Shin D; Francis C; Figg JW; Sebastian M; Font LF; Jin D; Reid A; Moore G; Fernandez B; Wummer B; Kuizon C; Mitchell D; Flores CT
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36750252
[TBL] [Abstract][Full Text] [Related]
3. Effective immunotherapy against murine gliomas using type 1 polarizing dendritic cells--significant roles of CXCL10.
Fujita M; Zhu X; Ueda R; Sasaki K; Kohanbash G; Kastenhuber ER; McDonald HA; Gibson GA; Watkins SC; Muthuswamy R; Kalinski P; Okada H
Cancer Res; 2009 Feb; 69(4):1587-95. PubMed ID: 19190335
[TBL] [Abstract][Full Text] [Related]
4. T cell immunity in patients with malignant glioma: recent progress in dendritic cell-based immunotherapeutic approaches.
Akasaki Y; Black KL; Yu JS
Front Biosci; 2005 Sep; 10():2908-21. PubMed ID: 15970545
[TBL] [Abstract][Full Text] [Related]
5. Sequential delivery of interferon-alpha gene and DCs to intracranial gliomas promotes an effective antitumor response.
Tsugawa T; Kuwashima N; Sato H; Fellows-Mayle WK; Dusak JE; Okada K; Papworth GD; Watkins SC; Gambotto A; Yoshida J; Pollack IF; Okada H
Gene Ther; 2004 Nov; 11(21):1551-8. PubMed ID: 15343358
[TBL] [Abstract][Full Text] [Related]
6. Sepsis Inflammation Impairs the Generation of Functional Dendritic Cells by Targeting Their Progenitors.
Lu J; Sun K; Yang H; Fan D; Huang H; Hong Y; Wu S; Zhou H; Fang F; Li Y; Meng L; Huang J; Bai Z
Front Immunol; 2021; 12():732612. PubMed ID: 34566996
[TBL] [Abstract][Full Text] [Related]
7. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
8. The duration of signaling through CD40 directs biological ability of dendritic cells to induce antitumor immunity.
Watanabe S; Kagamu H; Yoshizawa H; Fujita N; Tanaka H; Tanaka J; Gejyo F
J Immunol; 2003 Dec; 171(11):5828-36. PubMed ID: 14634092
[TBL] [Abstract][Full Text] [Related]
9. Collagen scaffold microenvironments modulate cell lineage commitment for differentiation of bone marrow cells into regulatory dendritic cells.
Fang Y; Wang B; Zhao Y; Xiao Z; Li J; Cui Y; Han S; Wei J; Chen B; Han J; Meng Q; Hou X; Luo J; Dai J; Jing Z
Sci Rep; 2017 Feb; 7():42049. PubMed ID: 28169322
[TBL] [Abstract][Full Text] [Related]
10. Adoptive transfer of dendritic cells expressing CD11c reduces the immunological response associated with experimental colitis in BALB/c mice.
Paiatto LN; Silva FGD; Yamada ÁT; Tamashiro WMSC; Simioni PU
PLoS One; 2018; 13(5):e0196994. PubMed ID: 29738575
[TBL] [Abstract][Full Text] [Related]
11. Different Human Immune Lineage Compositions Are Generated in Non-Conditioned NBSGW Mice Depending on HSPC Source.
Hess NJ; Lindner PN; Vazquez J; Grindel S; Hudson AW; Stanic AK; Ikeda A; Hematti P; Gumperz JE
Front Immunol; 2020; 11():573406. PubMed ID: 33193358
[TBL] [Abstract][Full Text] [Related]
12. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
[TBL] [Abstract][Full Text] [Related]
13. An experimental study of dendritic cells-mediated immunotherapy against intracranial gliomas in rats.
Zhu X; Lu C; Xiao B; Qiao J; Sun Y
J Neurooncol; 2005 Aug; 74(1):9-17. PubMed ID: 16078102
[TBL] [Abstract][Full Text] [Related]
14. Nrf2 suppresses the function of dendritic cells to facilitate the immune escape of glioma cells.
Wang J; Liu P; Xin S; Wang Z; Li J
Exp Cell Res; 2017 Nov; 360(2):66-73. PubMed ID: 28782555
[TBL] [Abstract][Full Text] [Related]
15. Induction of potent antitumor immunity by intratumoral injection of interleukin 23-transduced dendritic cells.
Hu J; Yuan X; Belladonna ML; Ong JM; Wachsmann-Hogiu S; Farkas DL; Black KL; Yu JS
Cancer Res; 2006 Sep; 66(17):8887-96. PubMed ID: 16951206
[TBL] [Abstract][Full Text] [Related]
16. CD11c
Ebrahimi-Nik H; Corwin WL; Shcheglova T; Das Mohapatra A; Mandoiu II; Srivastava PK
Cancer Immunol Immunother; 2018 Sep; 67(9):1449-1459. PubMed ID: 30030558
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P
J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360
[TBL] [Abstract][Full Text] [Related]
18. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
[TBL] [Abstract][Full Text] [Related]
19. Uptake and presentation of malignant glioma tumor cell lysates by monocyte-derived dendritic cells.
De Vleeschouwer S; Arredouani M; Adé M; Cadot P; Vermassen E; Ceuppens JL; Van Gool SW
Cancer Immunol Immunother; 2005 Apr; 54(4):372-82. PubMed ID: 15692847
[TBL] [Abstract][Full Text] [Related]
20. Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.
Liau LM; Black KL; Prins RM; Sykes SN; DiPatre PL; Cloughesy TF; Becker DP; Bronstein JM
J Neurosurg; 1999 Jun; 90(6):1115-24. PubMed ID: 10350260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
